The story of Sildenafil presents a complex case for stakeholders in the medicinal sector. While initially a tremendous success, generating vast sums, the intellectual property end and the subsequent arrival of https://gambling428722.theblogfairy.com/40545287/the-little-copyright-and-the-pharmaceutical-industry-a-hazardous-bet